Melbourne, Australia – Starpharma Holdings Ltd (ASX:SPL; OTCQX:SPHRY) is pleased to provide investors with the opportunity to listen to an audio interview with Chief Executive Officer Dr Jackie Fairley on Boardroom Radio (BRR).

Dr Fairley is discussing the Company’s recent announcement that its clinical-stage dendrimer SPL7013 has shown potent antiviral effect against adenovirus, the agent responsible for the majority of viral conjunctivitis cases, and the potential for the dendrimer’s development as a therapeutic for this condition.

The interview also refers to the status of other development programs at Starpharma, a number of which are in late stage development.

To listen, copy the following link into your web browser:

http://www.brrmedia.com/event/111995

Download ASX Announcement: Starpharma Boardroom Radio Interview ( pdf file, 61kb)